Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
January 10, 2017
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Study Phase : Phase IV
Sponsor : Massachusetts General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
June 16, 2016
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Highest Development Status : Phase IV
Sponsor : Massachusetts General Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
April 26, 2016
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
February 17, 2016
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Bioequivalence Study of Two Albiglutide Drug Products in Healthy Adult Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
January 21, 2016
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study Evaluating the Effect of Albiglutide on Gallbladder Emptying in Healthy Subjects
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
July 14, 2015
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Study Phase : Phase IV
Sponsor : Duke Clinical Research Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
June 08, 2015
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Highest Development Status : Phase IV
Sponsor : Duke Clinical Research Institute
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
November 05, 2014
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Study Phase : Phase III
Sponsor : PPD
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
September 01, 2014
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Highest Development Status : Phase III
Sponsor : PPD
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Study Phase : Phase III
Sponsor : PPD
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
September 01, 2014
Lead Product(s) : Albiglutide
Therapeutic Area : Endocrinology
Highest Development Status : Phase III
Sponsor : PPD
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
